Prostate-specific Membrane Antigen (PSMA)-specific Monoclonal Antibodies in the Treatment of Prostate and Other Cancers
Authors:
- 1 December 1999
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 18 (4) , 483-490
Abstract
Prostate-specific membrane antigen (PSMA) is a cell surface glycoprotein that is expressed by prostate epithelial cells. PSMA-specific monoclonal antibodies have been utilized to characterize the...Keywords
This publication has 23 references indexed in Scilit:
- Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissuesCancer, 2000
- ( 111 ) INDIUM-CAPROMAB PENDETIDE UNEXPECTEDLY LOCALIZES TO RENAL CELL CARCINOMAJournal of Urology, 1999
- ProstaScint® scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: Analysis of 136 scans of 100 patientsThe Prostate, 1998
- Molecular Characterization of Human Brain N-Acetylated α-Linked Acidic Dipeptidase (NAALADase)The Journal of Pharmacology and Experimental Therapeutics, 1998
- Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinomaCancer, 1998
- The T-body approach: potential for cancer immunotherapySpringer Seminars in Immunopathology, 1996
- Localization and Physical Mapping of the Prostate-Specific Membrane Antigen (PSM) Gene to Human Chromosome 11Genomics, 1995
- Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluidsInternational Journal of Cancer, 1995
- Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigenUrologic Oncology: Seminars and Original Investigations, 1995
- Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissuesUrologic Oncology: Seminars and Original Investigations, 1995